EP 4153193 A4 20240228 - COPPER ION COMPOSITIONS AND METHODS OF TREATMENT FOR CONDITIONS CAUSED BY CORONAVIRUS AND INFLUENZA
Title (en)
COPPER ION COMPOSITIONS AND METHODS OF TREATMENT FOR CONDITIONS CAUSED BY CORONAVIRUS AND INFLUENZA
Title (de)
KUPFERIONENZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG VON ERKRANKUNGEN INFOLGE VON CORONAVIRUS UND INFLUENZA
Title (fr)
COMPOSITIONS D'IONS CUIVRE ET MÉTHODES DE TRAITEMENT D'ÉTATS PROVOQUÉS PAR LE CORONAVIRUS ET LA GRIPPE
Publication
Application
Priority
- US 202016881937 A 20200522
- US 2021024555 W 20210329
Abstract (en)
[origin: WO2021236231A1] Provided herein are formulations containing copper ions and methods of treating underlying infections and conditions caused by coronavirus, particularly COVID-19, and influenzas, particularly influenza A and/or influenza B using such formulations. Methods of treating the underlying viruses and their resultant conditions using topical copper ion treatments are provided. A topical treatment in its basic form comprises a biocompatible copper ion solution or suspension obtained by leaching of the copper ions from copper metal. The copper ion solution or suspension may be combined with various carriers to form the copper ion treatment including creams or solutions. Methods of making the copper ion solution or suspension from solid copper metal in a biocompatible solution are also provided.
IPC 8 full level
A61K 33/34 (2006.01); A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 9/10 (2006.01); A61K 47/12 (2006.01); A61L 26/00 (2006.01); A61P 31/14 (2006.01)
CPC (source: EP)
A61K 9/0014 (2013.01); A61K 9/0078 (2013.01); A61K 9/008 (2013.01); A61K 33/34 (2013.01); A61P 31/14 (2018.01); A61K 9/0046 (2013.01); A61K 9/06 (2013.01); A61K 9/10 (2013.01); A61K 47/12 (2013.01)
Citation (search report)
- [E] WO 2021222230 A1 20211104 - OYSTER POINT PHARMA INC [US]
- [I] US 2014271495 A1 20140918 - ABBOTT CHUN LIM [US], et al
- [I] RAHA SYAMAL ET AL: "Is copper beneficial for COVID-19 patients?", MEDICAL HYPOTHESES, EDEN PRESS, PENRITH, US, vol. 142, 5 May 2020 (2020-05-05), XP086252223, ISSN: 0306-9877, [retrieved on 20200505], DOI: 10.1016/J.MEHY.2020.109814
- See also references of WO 2021236231A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2021236231 A1 20211125; AU 2021274625 A1 20230105; CA 3184333 A1 20211125; EP 4153193 A1 20230329; EP 4153193 A4 20240228; JP 2023526867 A 20230623; KR 20230038422 A 20230320
DOCDB simple family (application)
US 2021024555 W 20210329; AU 2021274625 A 20210329; CA 3184333 A 20210329; EP 21807576 A 20210329; JP 2022571815 A 20210329; KR 20227045012 A 20210329